|
||||||||||||||||
|
||||||||||||||||
The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy. Invited Experts Between December 1, 2004, and June 27, 2005 Alan Breier Vice President, Medical and Chief Medical Officer Eli Lilly and Company Catherine D.DeAngelis Editor-in-Chief Journal of the American Medical Association Jeffrey M.Drazen Editor-in-Chief New England Journal of Medicine Lawrence Hirsch Executive Director, Medical Communications Merck Research Laboratories John Hoey Editor Canadian Medical Association Journal Christine Laine Executive Secretary Annals of Internal Medicine Justin McCarthy General Counsel, Pfizer Global Research and Development Pfizer, Inc. Frank Rockhold Senior Vice President and Director, Biomedical Data Sciences GlaxoSmithKline Pharmaceuticals Research and Development Alfred Sandrock Vice President, Medical Research-Neurology Biogen Idec Ralph Smalling Vice President, Global Research and Development Policy Analysis Amgen Harold Sox Editor Annals of Internal Medicine
|
|
|||||||||||||||
